Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-20290 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- SLUG Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- A suggested positive control is 293 cell lysate.
- Concentration
- 1 mg/mL
Submitted references Hepatitis B Virus Covalently Closed Circular DNA Predicts Postoperative Liver Cancer Metastasis Independent of Virological Suppression.
Hsu CW, Chu YD, Lai MW, Lin CL, Liang KH, Lin YH, Yeh CT
Cancers 2021 Jan 31;13(3)
Cancers 2021 Jan 31;13(3)
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of 293 cell lysate using a Slug polyclonal antibody (Product # PA5-20290) at in (A) 0.5, (B) 1 and (C) 2 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot analysis of SLUG expression in (A) human and (B) mouse kidney tissue lysate with SLUG Polyclonal Antibody (Product # PA5-20290) at 0.5 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot analysis of Slug in 293 cell lysate with SLUG Polyclonal Antibody (Product # PA5-20290) at in (A) 0.5, (B) 1 and (C) 2 µg/mL.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence of Slug in human kidney tissue with SLUG Polyclonal Antibody (Product # PA5-20290) at 20 µg/mL.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 5 Association between the expression levels of epithelial-mesenchymal transition (EMT) markers, Twist1 and Slug, and postoperative outcomes in patients with HBV-related HCC. ( A - C ) Representative Western blots for an assessment of Twist1 and Slug expression levels in tissue samples derived from HCC patients. Densitometry was used for quantification. ( D ) Comparison of extrahepatic metastasis free survival (EMFS) between patients with high and low tumor/non-tumor (T/N) ratios of Twist1. Please find the western blot in Supplementary Files . ( E ) Comparison of EMFS between patients with high and low slug expression in cancerous tissues. The Kaplan-Meier analysis was performed. The cutoff of Twist T/N ratio (0.9) was determined by the minimal p -value approach [].